Długosz A. Stokłosa A. Kłodnicka A. Ginekol. Pol. 2007, 78, 632-636.
Parkinson P. Ogilvie BW. Buckley DB. Kazmi F. Czerwiński M., Parkinson O. w Klaassen C. [Edit.]. Casarett & Doull’s Toxicology, The Basic Science of Poisons, McGraw-Hill Education, London 2013.
Anzenbacher P. Eva Anzenbacherová E. w: Anzenbacher P. Tanger UM. [Edit.]: Metabolism of drugs and other xenobiotics. Wiley-VCH Verlag GmbH & Co. KGaA, Dresden 2012.
DOI: https://doi.org/10.1002/9783527630905
Maruyama M. Matsunaga T. Harada E. Ohmori S. Biol. Pharm. Bull. 2007, 30(11), 2091-207.
DOI: https://doi.org/10.1248/bpb.30.2091
Lu C. Miwa GT. Prakash S.R. Gani L-S. Balani SK. Drug. Metab. Dispos. 2007, 35(1), 79-85.
DOI: https://doi.org/10.1124/dmd.106.011346
Michalets EL. Pharmacotherapy 1998, 18, 84-112.
DOI: https://doi.org/10.1002/j.1875-9114.1998.tb03830.x
Skagen KJ. Interindividual Variability in the Cytochrome P450 3A4 drug metabolizing enzyme: effect of the CYP3A4*1G genetic variant. University of Montana Missoula 2014, http://scholarworks.umt.edu.
Lewis DF. Pharmacogenomic 2004, 5(3), 305-318.
DOI: https://doi.org/10.1517/phgs.5.3.305.29827
McKinnon RA. Sorich MJ., Ward MB. J Pharm. Pract. Res. 2008, 38(1), 55-57.
DOI: https://doi.org/10.1002/j.2055-2335.2008.tb00798.x
Meunier B. de Visser SP. Sason Shaik S. Chem. Rev. 2004, 104, 3947-3980.
DOI: https://doi.org/10.1021/cr020443g
Tompkins LM., Wallace AD. J. Biochem. Mol. Toxicol. 2007, 21(4), 176-81.
DOI: https://doi.org/10.1002/jbt.20180
Zanger UM. Schwab M. Pharmacol. Ther. 2013, 138, 103-141.
DOI: https://doi.org/10.1016/j.pharmthera.2012.12.007
Thummel KE.J. Clin. Invest. 2007, 117(11), 3173-3176.
DOI: https://doi.org/10.1172/JCI34007
Ohtsuki S. Schaefe, O. Kawakami H. Inoue T. Liehner S. Saito A. Ishiguro N. Kishimoto W. Ludwig-Schwellinger E. Ebner T. Terasaki T. Drug Metab. Dispos. 2012, 40, 83-92.
DOI: https://doi.org/10.1124/dmd.111.042259
Kliewer SA. Goodwin B. Willson TM. Endocrine Rev. 2002, 23, 687-702.
DOI: https://doi.org/10.1210/er.2001-0038
GenAtlas human gene database, http://genatlas.medecine.univ-paris5.fr/.
William JA. Ring BJ. Cantrell VE. Jones DR. Eckstein J. Ruterbories K. Drug Metab. Dispos. 2002, 30, 883-891.
DOI: https://doi.org/10.1124/dmd.30.8.883
Daly AK. Clin. Pharmacokinet. 2006, 45, 13-31.
DOI: https://doi.org/10.2165/00003088-200645010-00002
Medsafe. Drug Metabolism - The Importance of Cytochrome P450 3A4. Prescriber Update 35(1), 4-6.
Soldin OP. Chung SH. Mattison DR. J. Biomed. Biotech. 2011, 2011, 1-14.
DOI: https://doi.org/10.1155/2011/187103
Johnson EF. Biochem. Biophys. Res. Commun. 2005, 338, 331-336.
DOI: https://doi.org/10.1016/j.bbrc.2005.08.190
Guengerich FP. Annu. Rev. Pharmacol. Toxicol. 1999, 39, 1-17.
DOI: https://doi.org/10.1146/annurev.pharmtox.39.1.1
Orans J. Teotico DG. Redinbo MR. Mol. Endocrinol. 2005, 19, 2891-2900.
DOI: https://doi.org/10.1210/me.2005-0156
Sinz M.W. Drug Metabol. Rev. 2013, 45(1), 3-14.
DOI: https://doi.org/10.3109/03602532.2012.743560
Kobayashi T. Kodani Y. Nozawa A. Endo Y. Sawasaki T. FEBS Lett. 2008, 582(18), 2737-2744.
DOI: https://doi.org/10.1016/j.febslet.2008.07.003
Luo G. Cunningham M. Kim S. Burn T. Lin J. Sinz M. Hamilton G. Rizzo Ch. Jolley S. Gilbert D. Downey A. Mudra D. Graham R. Karoll K. Xie J. Madan A. Parkinson A. Christ D. Selling B. Lecluyse E. Gan L-S. Drug. Metabol. Dis. 2002, 30(7), 795-804.
DOI: https://doi.org/10.1124/dmd.30.7.795
Hasegawa M. Kapelyukh Y. Tahara H. Seibler J. Rode A. Krueger S. Mol. Pharmacol. 2011, 80, 518-528.
DOI: https://doi.org/10.1124/mol.111.071845
Kliewer SA. J. Nutr. 2003, 133, 2444S-2447S.
DOI: https://doi.org/10.1093/jn/133.7.2444S
Matic M. Mahns A. Tsoli M. Corradin A. Polly P. Rpbertson GR. Int. J. Biochem. Cell Biol. 2007, 39, 478-483.
DOI: https://doi.org/10.1016/j.biocel.2006.08.017
Martinez-Jimenez CP. Jover R. Donato MT. Castell JV. Gomez-Lechon MJ. Curr. Drug Metab. 2007, 8, 185-194.
DOI: https://doi.org/10.2174/138920007779815986
Haddad A. Davis M. Langman R. Support Care Cancer 2007, 15, 251-257.
DOI: https://doi.org/10.1007/s00520-006-0127-5
LeCluyse E.L. Chem. Biol. Interact. 2001, 134, 283-28.
DOI: https://doi.org/10.1016/S0009-2797(01)00163-6
Kliewer S.A. Willson T.M. J. Lipid Res. 2002, 43, 359-364.
DOI: https://doi.org/10.1016/S0022-2275(20)30141-3
Handshin C. Meyer UA. Arch. Biochem. Biophys. 2005, 433, 387-396.
DOI: https://doi.org/10.1016/j.abb.2004.08.030
Zhang S. Pan X. Jeong H. Drug Metab. Dispos. 2015, 43, 743-748.
DOI: https://doi.org/10.1124/dmd.114.062836
Hariparsad N. Chu X. Yabut J. Labhart P. Hartley D.P. Dai X. Evers R. Nucleic Acids Res. 2009, 37, 1160-1173.
DOI: https://doi.org/10.1093/nar/gkn1047
Soisson SM. Parthasarathy G. Adams AD. Sahoo S. Sitlani A. Sparrow C. Jisong Cui J. Becker JW. PNAS 2008, 105(14), 5337-5342.
DOI: https://doi.org/10.1073/pnas.0710981105
Wang YD. Chen WD. Moore DD. Huang W. Cell Res. 2008, 18(11), 1087-1095.
DOI: https://doi.org/10.1038/cr.2008.289
Chen J. Zhao K-N. Chen Ch. Ann. Transl. Med. 2014, 2(1), 7-15.
Zhang J. Tian Q. Yung Chan S. Drug Metab. Rev. 2005, 37, 611-703.
DOI: https://doi.org/10.1080/03602530500364023
Fukumori S. Murata T. Taguchi M. Hashimoto Y. Drug Metab. Pharmacokinet. 2007, 22, 377-381.
DOI: https://doi.org/10.2133/dmpk.22.377
Thummel K.E. Brimer C. Yasuda K. Thottassery J. Senn T. Lin Y. Mol. Pharmacol. 2001, 60, 1399-1406.
DOI: https://doi.org/10.1124/mol.60.6.1399
Makishima M. Lu TT. Xie W. Whitfield GK. Domoto H. Evans RM. Science 2002, 296, 1313-1316.
DOI: https://doi.org/10.1126/science.1070477
Kobayashi K. Sueyoshi T. Inoue K. Moore R. Negishi M. Mol. Pharmacol. 2003, 64, 1069-1075.
DOI: https://doi.org/10.1124/mol.64.5.1069
Moore LB. Parks DJ. Jones SA. Bledsoe RK. Consler TG. Stimmel JB. Goodwin B. Liddle C. Blanchard SG. Wilson TM., Collins JL. Kliewer SA. J. Biol. Chem. 2000a, 275, 15122-15227.
DOI: https://doi.org/10.1074/jbc.M001215200
English
Język Polski
